| New carbapenemase inhibitors: clearing the way for the β-lactams JC Vázquez-Ucha, J Arca-Suárez, G Bou, A Beceiro International journal of molecular sciences 21 (23), 9308, 2020 | 112 | 2020 |
| Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas … J Arca-Suárez, C Lasarte-Monterrubio, BK Rodiño-Janeiro, G Cabot, ... Journal of Antimicrobial Chemotherapy 76 (1), 91-100, 2021 | 52 | 2021 |
| Selection of AmpC β-lactamase variants and metallo-β-lactamases leading to ceftolozane/tazobactam and ceftazidime/avibactam resistance during treatment of MDR/XDR Pseudomonas … A Ruedas-López, I Alonso-García, C Lasarte-Monterrubio, ... Antimicrobial Agents and Chemotherapy 66 (2), e02067-21, 2022 | 44 | 2022 |
| Assessment of activity and resistance mechanisms to cefepime in combination with the novel β-lactamase inhibitors zidebactam, taniborbactam, and enmetazobactam against a … JC Vázquez-Ucha, C Lasarte-Monterrubio, P Guijarro-Sánchez, M Oviaño, ... Antimicrobial Agents and Chemotherapy 66 (2), e01676-21, 2022 | 44 | 2022 |
| Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales JC Vázquez-Ucha, A Seoane-Estévez, BK Rodiño-Janeiro, ... Journal of Antimicrobial Chemotherapy 76 (6), 1498-1510, 2021 | 44 | 2021 |
| Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis MÀ Sastre-Femenia, A Fernández-Muñoz, MA Gomis-Font, B Taltavull, ... The lancet regional health–Europe 34, 2023 | 40 | 2023 |
| Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection J Arca-Suárez, JC Vázquez-Ucha, PA Fraile-Ribot, E Lence, G Cabot, ... Journal of Antimicrobial Chemotherapy 75 (11), 3209-3217, 2020 | 38 | 2020 |
| Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam-and ceftazidime/avibactam-resistant Pseudomonas … C Lasarte-Monterrubio, PA Fraile-Ribot, JC Vázquez-Ucha, G Cabot, ... Journal of Antimicrobial Chemotherapy 77 (10), 2809-2815, 2022 | 37 | 2022 |
| Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group A Oliver, E Rojo-Molinero, J Arca-Suarez, Y Beşli, P Bogaerts, R Cantón, ... Clinical microbiology and infection 30 (4), 469-480, 2024 | 29 | 2024 |
| First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain F Fernández-Cuenca, P Pérez-Palacios, F Galán-Sánchez, ... Enfermedades infecciosas y microbiologia clinica (English ed.) 38 (1), 11-15, 2020 | 29 | 2020 |
| Challenging antimicrobial susceptibility and evolution of resistance (OXA-681) during treatment of a long-term nosocomial infection caused by a Pseudomonas aeruginosa ST175 clone J Arca-Suárez, P Fraile-Ribot, JC Vázquez-Ucha, G Cabot, ... Antimicrobial agents and chemotherapy 63 (10), 10.1128/aac. 01110-19, 2019 | 27 | 2019 |
| Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing J Arca-Suárez, BK Rodiño-Janeiro, A Pérez, P Guijarro-Sánchez, ... International Journal of Antimicrobial Agents 59 (1), 106456, 2022 | 25 | 2022 |
| Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella … JC Vázquez-Ucha, M Martínez-Guitián, C Lasarte-Monterrubio, ... Biomedicine & Pharmacotherapy 130, 110606, 2020 | 24 | 2020 |
| Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain JC Vázquez-Ucha, I Alonso-Garcia, P Guijarro-Sánchez, ... International Journal of Antimicrobial Agents 61 (4), 106738, 2023 | 16 | 2023 |
| 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics JC Vazquez-Ucha, D Rodriguez, C Lasarte-Monterrubio, E Lence, ... Journal of Medicinal Chemistry 64 (9), 6310-6328, 2021 | 16 | 2021 |
| In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification E Gato, P Guijarro-Sánchez, I Alonso-García, R Pedraza-Merino, A Conde, ... International Journal of Antimicrobial Agents 62 (4), 106935, 2023 | 14 | 2023 |
| Direct detection of carbapenemase-producing Klebsiella pneumoniae by MALDI-ToF analysis of full spectra applying machine learning E Gato, MJ Arroyo, G Méndez, A Candela, BK Rodiño-Janeiro, ... Journal of Clinical Microbiology 61 (6), e01751-22, 2023 | 13 | 2023 |
| Antimicrobial activity of cefiderocol against the carbapenemase-producing enterobacter cloacae complex and characterization of reduced susceptibility associated with metallo-β … C Lasarte-Monterrubio, P Guijarro-Sánchez, JC Vázquez-Ucha, ... Antimicrobial agents and chemotherapy 67 (5), e01505-22, 2023 | 13 | 2023 |
| Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain J Arca-Suárez, F Galán-Sánchez, F Cano-Cano, G García-Santos, ... Anaerobe 54, 146-150, 2018 | 13 | 2018 |
| Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR … I Alonso-García, JC Vázquez-Ucha, C Lasarte-Monterrubio, ... Journal of Antimicrobial Chemotherapy 78 (5), 1195-1200, 2023 | 10 | 2023 |
Alejandro BeceiroINIBIC-SERGASAdresse e-mail validée de sergas.es
